Additional work-up with an 18fluorine-DCFPyL prostate-specific membrane antigen (PSMA) scan demonstrated no abnormal uptake within the prostate or metastatic disease, regionally or distantly. The gene discussed is FOLH1; the disease is metastatic neoplasm.